Nicholas Investment Partners’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-184,358
| Closed | -$2.17M | – | 235 |
|
|
2024
Q2 | $2.17M | Buy |
184,358
+1,714
| +0.9% | +$20.2K | 0.23% | 139 |
|
|
2024
Q1 | $2.17M | Buy |
+182,644
| New | +$2.17M | 0.22% | 147 |
|
|
2021
Q4 | – | Sell |
-217,389
| Closed | -$3.79M | – | 204 |
|
|
2021
Q3 | $3.79M | Sell |
217,389
-433,514
| -67% | -$7.57M | 0.28% | 121 |
|
|
2021
Q2 | $15.6M | Buy |
650,903
+56,773
| +10% | +$1.36M | 0.98% | 36 |
|
|
2021
Q1 | $15.3M | Buy |
+594,130
| New | +$15.3M | 1.06% | 33 |
|